Tulisokibart
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Tulisokibart, covering 2023-11-01 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) [Phase 3]